NRX PHARMACEUTICALS, INC. (NRXP) DISCUSSES FDA FIRST CYCLE REVIEW OUTCOME AND COMMERCIALIZATION PLANS FOR PRESERVATIVE FREE KETAMINE TRANSCRIPT - SEEKINGALPHA

FDA first cycle review outcome and ketamine commercialization plans signal major regulatory catalyst.